98%
921
2 minutes
20
Background: Wilson's disease is an inherited genetic disorder of hepatic copper metabolism characterized by hepatic, neurological, and psychiatric manifestations. Patients with neurological symptoms manifest remarkable variability regarding type and severity. This study aimed to characterize neurological signs and symptoms of patients with Wilson's disease in Southwest China and identify factors associated with neurological symptoms in patients with Wilson's disease.
Methods: A total of 109 treated patients with Wilson's disease were included in the study. Sociodemographic and clinical data were obtained through face-to-face interviews and medical record reviews. ATP7B mutations were identified through whole-genome resequencing. Neurological signs and symptoms were assessed using the neurological part of the Unified Wilson's Disease Rating Scale (UWDRS Part I). Multiple linear regression analysis was performed to assess the association between patient characteristics and UWDRS Part I scores.
Results: The most prevalent neurological symptoms of patients with Wilson's disease were impaired rapid alternating movements of hands (76.2-81.0%), impaired finger tapping (75.0%), dysarthria (70.2%), salivation (66.7%), impaired handwriting (61.9%), impaired legs agility (60.7-61.9%), impaired gait (leg dystonia, 59.5%; ataxia, 58.3%), and dystonia of arms and hands (54.8-56.0%). Sex and age differences were observed in the neurological features of Wilson's disease. Sociodemographic and clinical factors associated with the severity of neurological symptoms included occupation, family per capita monthly income, initial clinical subtype, adherence to low-copper diets, and mental health conditions, with an explanatory power of 42.1% (F = 10.474, p < 0.001). Genotype-phenotype analysis showed that patients carrying the p.P992L mutation had a significantly higher frequency of impaired finger tapping (p = 0.037).
Conclusion: The main neurological symptoms in this study of treated patients with Wilson's disease were lack of motor coordination, dystonia, dysarthria, and salivation. This study identified five factors associated with the severity of neurological symptoms and revealed a potential association between the p.P992L mutation and a specific neurological manifestation. These results may enhance the understanding of Wilson's disease, guide future management of patients to alleviate neurological symptoms and improve prognosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12228280 | PMC |
http://dx.doi.org/10.1186/s13023-025-03874-2 | DOI Listing |
Ann Clin Transl Neurol
September 2025
Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Objective: Neuroinflammation driven by extracellular copper contributes to neuronal damage in Wilson's disease (WD). This study investigated the relationship between brain metal burden and peripheral neuroinflammation markers in WD.
Methods: We conducted a cross-sectional study involving 89 participants, including patients with WD (n = 63), asymptomatic ATP7B heterozygous carriers (n = 12), and age/sex-matched controls (n = 14).
Curr Med Chem
August 2025
Shanghai Key Lab of Forensic Medicine, Key Lab of Forensic Science, Ministry of Justice, China (Academy of Forensic Science), Shanghai, 200063, China.
Introduction: This paper provides a comprehensive review examining the application of copper radionuclides, particularly 64Cu, in the diagnosis and potential therapy of various brain diseases.
Methods: Two researchers conducted an independent search of the PubMed and Web of Science databases for original research articles published in English. Following a screening process based on titles and abstracts, 42 publications reporting the use of copper radionuclides for diagnosing or treating brain diseases were selected for this review.
The anthelmintic praziquantel (PZQ) has been used for decades as the clinical therapy for schistosomiasis, and remains the only available drug. As a cheap and effective drug therapy for all human disease-causing species, usage of PZQ underpins mass drug administration strategies aimed at eliminating schistosomiasis as a public health problem by 2030. Concern over the potential emergence of resistance to PZQ is therefore warranted, as it would constitute a major threat to this approach.
View Article and Find Full Text PDFBMJ Paediatr Open
September 2025
Directorate General of Health Services, Dhaka, Bangladesh.
Diagnosing Wilson's disease (WD) in children remains a significant challenge. This study evaluated spot urinary copper/creatinine (Cu/Cr) ratio for paediatric WD diagnosis in Bangladesh. 60 children (30 WD, 30 non-WD by Leipzig criteria) were enrolled, and the spot morning urinary Cu/Cr and 24-hour urinary copper were measured.
View Article and Find Full Text PDFFuture Cardiol
September 2025
Surgery, St. Anna Hospital, Herne, Germany.
Introduction: Wilson's disease (WD) is a rare autosomal recessive disorder caused by ATP7B gene mutations, leading to systemic copper accumulation. This systematic review examines the cardiac manifestations of WD and aims to summarize key diagnostic and therapeutic findings from available studies.
Methods: We conducted a systematic review of 21 studies using databases such as PubMed and Scopus.